Table 3 Multivariate logistic regression analysis of the factors related to QT prolongation.
From: A randomized controlled trial of the short-term effect of rosuvastatin on the corrected QT interval
Variables | OR (95%CI) | p | OR (95%CI) | p |
|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
Age | 1.68 (1.30–2.18) | < 0.001 | 1.45 (1.11–1.91) | 0.007 |
Atrial fibrillation | 4.92 (2.24–10.80) | < 0.001 | 2.89 (1.24–6.74) | 0.014 |
Heart failure | 5.25 (2.61–10.58) | < 0.001 | 3.85 (1.83–8.12) | < 0.001 |
Creatinine | 1.11 (1.01–1.22) | 0.003 | -- | -- |
Serum calcium | 0.60 (0.44–0.80) | < 0.001 | 0.72 (0.53–0.99) | 0.042 |
Serum magnesium | 0.62 (0.41–0.93) | 0.032 | -- | -- |
LVEF | 0.93 (0.90–0.96) | < 0.001 | -- | -- |
LVDs | 1.14 (1.08–1.21) | < 0.001 | -- | -- |
LVDd | 1.19 (1.12–1.26) | < 0.001 | -- | -- |
